As per the research report, the size of the Middle East and Africa Contrast Injector Market is valued at USD 66.48 million in 2021 and is projected to be growing at a CAGR of 5.73%, to touch USD 87.82 million by 2026 during the forecast period 2021 to 2026.
Contrast Injectors are widely used in the techniques of magnetic resonance imaging (MRI), computed tomography and interventional radiology. Contrast Injectors have the capability to deliver precise amounts of contrast agents at required flow rates which helps substantively in medical imaging procedures.
The transfer of contrast media into the human body, through the bloodstream, is considered most efficient and effective by the use of a medical device known as a power injector or contrast injector. A medical contrast medium is a substance used to enhance the contrast of fluids or structures within the body, for medical imaging.
The growth of the Middle East and Africa Contrast Injector Market is driven by the increasing use of Contrast Injectors due to rising approvals for the use of contrast media. This is further supplemented by the increasing integration of IT and the major cost savings offered by contrast injectors, which automate a lot of manual procedures. However, side reactions and side effects related to the use of contrast media are expected to be the factors limiting market growth, to a certain extent.
This research report on the MEA Contrast Injector Market has been segmented and sub-segmented into the following categories:
By Product:
By Application:
By Country:
The increasing number of private and public diagnostic centers involving modern imaging techniques, which consequently lead to increased demand for contrast media, are expected to drive the market growth of the region in the near future. The presence of huge untapped markets, particularly in the countries of Africa, further offers potential for market growth.
The leading companies leading in the MEA Contrast Injector Market profiled in the report are Bracco Imaging S.p.A. (Italy), Bayer HealthCare (Germany), Guerbet Group (France), Medtron AG (Germany), ulrich GmbH & Co. KG (Germany), GE Healthcare (U.S.), AngioDynamics (U.S.), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical- Device Technology Co., Ltd. (China), VIVID IMAGING (China), and Apollo RT Co., Ltd. (China).
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Product
5.1.1 Introduction
5.1.2 Injector Systems
5.1.2.1 CT Injector Systems
5.1.2.2 MRI Injector Systems
5.1.2.3 Angiography Injector Systems
5.1.3 Consumables
5.1.3.1 Injector Heads
5.1.3.2 Syringes
5.1.3.3 Tubing
5.1.3.4 Other Consumables
5.1.4 Accessories
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Radiology
5.2.3 Interventional Cardiology
5.2.4 Interventional Radiology
5.2.5 Y-o-Y Growth Analysis, By Application
5.2.6 Market Attractiveness Analysis, By Application
5.2.7 Market Share Analysis, By Application
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Application
6.2 Middle-East
6.3 Africa
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Bracco Imaging S.p.A.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Bayer HealthCare
8.3 Guerbet Group
8.4 Medtron AG
8.5 ulrich GmbH & Co. KG
8.6 GE Healthcare
8.7 AngioDynamics
8.8 Nemoto Kyorindo Co.
8.9 Sino Medical- Device Technology
8.10 VIVID IMAGING
8.11 Apollo RT Co.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
